You’re on our free ad-supported tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Novartis
Pharmaceuticals
GSK
AstraZeneca
Novo Nordisk
Sanofi
Johnson and Johnson
Eli Lilly
Abbott Labs
Topics

Advertisement

Novartis

Share

Top Latest Popular

Mohw, Novartis ink 140B won deal to strengthen RLT supply chain Asia Today 3d

Asia Today 3d

Novartis India Q1 profit up 16%, revenue climbs 18%; shares fall 3% The Financial Express 2d

The Financial Express 2d

Novartis India Pharma

Novartis Q2 earnings & revenues top estimates, key drugs perform well Zacks 3d

Zacks 3d

Novartis Q2 Pharma

Advertisement

Advertisement

Stat Plus: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more STAT 14:03 Mon, 06 Jul

STAT 14:03 Mon, 06 Jul

Novartis stock gains on core operating income, volume growth in Q2; backs outlook RTT News 4d

RTT News 4d

Can Novartis' Fabhalta strengthen its nephrology franchise? Zacks 7d

Zacks 7d

Novartis Fabhalta Pharma

Advertisement

Advertisement

Latest

In the last 8 hours

New clash between Georgiadis and Salmas over Novartis case: “He is serving reheated conspiracy claims” – “He is adopting Polakis’ allegations” Proto Thema News 20:28 Fri, 24 Jul

Thursday

Novartis India Q1 profit up 16%, revenue climbs 18%; shares fall 3% The Financial Express 09:38 Thu, 23 Jul

Novartis India standalone net profit rises 16.62% in the June 2026 quarter The Business Standard 09:29 Thu, 23 Jul

Wednesday

Car T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight PR Newswire (Press Release) 15:32 Wed, 22 Jul

Novartis CEO Praises Japan And Blasts Germany Over Pricing Scrip Pharma Intelligence 13:06 Wed, 22 Jul

MOHW, Novartis ink 140B won deal to strengthen RLT supply chain Asia Today 02:14 Wed, 22 Jul

Tuesday

Novartis to invest ₩140 bil. in Korea radioligand therapy ecosystem Korea Biomedical Review 22:10 Tue, 21 Jul

Novartis Q2 Earnings & Revenues Top Estimates, Key Drugs Perform Well Zacks 17:45 Tue, 21 Jul

Cosentyx Close To Peak $8bn Sales For Novartis Scrip Pharma Intelligence 16:15 Tue, 21 Jul

Compared to Estimates, Novartis (NVS) Q2 Earnings: A Look at Key Metrics Zacks 15:33 Tue, 21 Jul

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis